These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7887304

  • 1. Proximal signals and the control of S-phase entry in interleukin-2-stimulated T lymphocytes.
    Abraham RT, Karnitz LM, Burns LA, Brunn GJ.
    Adv Exp Med Biol; 1994; 365():197-210. PubMed ID: 7887304
    [No Abstract] [Full Text] [Related]

  • 2. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.
    Flanagan WM, Crabtree GR.
    Ann N Y Acad Sci; 1993 Nov 30; 696():31-7. PubMed ID: 8109837
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-2 receptor signaling mechanisms.
    Karnitz LM, Abraham RT.
    Adv Immunol; 1996 Nov 30; 61():147-99. PubMed ID: 8834496
    [No Abstract] [Full Text] [Related]

  • 4. IL-2 induces beta2-integrin adhesion via a wortmannin/LY294002-sensitive, rapamycin-resistant pathway. Phosphorylation of a 125-kilodalton protein correlates with induction of adhesion, but not mitogenesis.
    Nielsen M, Svejgaard A, Skov S, Dobson P, Bendtzen K, Geisler C, Odum N.
    J Immunol; 1996 Dec 15; 157(12):5350-8. PubMed ID: 8955182
    [Abstract] [Full Text] [Related]

  • 5. IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A.
    Turner JM.
    Int Immunol; 1993 Oct 15; 5(10):1199-209. PubMed ID: 8268127
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.
    Morice WG, Brunn GJ, Wiederrecht G, Siekierka JJ, Abraham RT.
    J Biol Chem; 1993 Feb 15; 268(5):3734-8. PubMed ID: 8429048
    [Abstract] [Full Text] [Related]

  • 7. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line.
    Karnitz LM, Sutor SL, Abraham RT.
    J Exp Med; 1994 Jun 01; 179(6):1799-808. PubMed ID: 7515100
    [Abstract] [Full Text] [Related]

  • 8. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
    Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC, Abraham RT.
    EMBO J; 1996 Oct 01; 15(19):5256-67. PubMed ID: 8895571
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.
    Metcalfe SM, Canman CE, Milner J, Morris RE, Goldman S, Kastan MB.
    Oncogene; 1997 Oct 02; 15(14):1635-42. PubMed ID: 9349496
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone.
    Monfar M, Blenis J.
    Mol Endocrinol; 1996 Sep 02; 10(9):1107-15. PubMed ID: 8885245
    [Abstract] [Full Text] [Related]

  • 11. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR.
    Nature; 1992 Jul 02; 358(6381):70-3. PubMed ID: 1614535
    [Abstract] [Full Text] [Related]

  • 12. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG, Shi Y, Mills GB, Miller RG.
    Cell Immunol; 1996 Jun 15; 170(2):260-73. PubMed ID: 8660826
    [Abstract] [Full Text] [Related]

  • 13. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
    Feuerstein N, Huang D, Hinrichs SH, Orten DJ, Aiyar N, Prystowsky MB.
    J Immunol; 1995 Jan 01; 154(1):68-79. PubMed ID: 7995960
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM.
    Nature; 1994 Dec 08; 372(6506):570-3. PubMed ID: 7990932
    [Abstract] [Full Text] [Related]

  • 15. Telomerase regulation during entry into the cell cycle in normal human T cells.
    Buchkovich KJ, Greider CW.
    Mol Biol Cell; 1996 Sep 08; 7(9):1443-54. PubMed ID: 8885238
    [Abstract] [Full Text] [Related]

  • 16. TOR controls translation initiation and early G1 progression in yeast.
    Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN.
    Mol Biol Cell; 1996 Jan 08; 7(1):25-42. PubMed ID: 8741837
    [Abstract] [Full Text] [Related]

  • 17. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF, Mayor J, Ball C, Chitko-McKown CG, Sakata N, Domenico-Hahn J, Lucas JJ, Gelfand EW.
    Cell Immunol; 1999 Oct 10; 197(1):19-29. PubMed ID: 10555992
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
    Terada N, Takase K, Papst P, Nairn AC, Gelfand EW.
    J Immunol; 1995 Oct 01; 155(7):3418-26. PubMed ID: 7561036
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW.
    J Cell Physiol; 1993 Jan 01; 154(1):7-15. PubMed ID: 8419408
    [Abstract] [Full Text] [Related]

  • 20. p70 S6 kinase: an enigma with variations.
    Proud CG.
    Trends Biochem Sci; 1996 May 01; 21(5):181-5. PubMed ID: 8871403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.